Both miR-17-5p and miR-20a Alleviate Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating STAT3 Expression
Authors:
Open Access
- 15 April 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 186 (8) , 4716-4724
Abstract
Myeloid-derived suppressor cells (MDSCs) were one of the major components of the immune suppressive network. STAT3 has an important role in regulating the suppressive potential of MDSCs. In this study, we found that the expression of STAT3 could be modulated by both miR-17-5p and miR-20a. The transfection of miR-17-5p or miR-20a remarkably reduces the expression of reactive oxygen species and the production of H2O2, which are regulated by STAT3. MDSCs transfected with miR-17-5p or miR-20a are less able to suppress Ag-specific CD4 and CD8 T cells. Importantly, both miR-17-5p and miR-20a alleviate the suppressive function of MDSCs in vivo. The expression of miR-17-5p and miR-20a in tumor-associated MDSCs was found to be lower than in Gr1+CD11b+ cells isolated from the spleens of disease-free mice. Tumor-associated factor downregulates the expression of both miR-17-5p and miR-20a. The modulation of miR-17-5p and miR-20a expression may be important for the process by which patients with a tumor can overcome the immune tolerance mediated by MDSCs. Our results suggest that miR-17-5p and miR-20a could potentially be used for immunotherapy against diseases, especially cancer, by blocking STAT3 expression.Keywords
This publication has 39 references indexed in Scilit:
- mir-17-92, a cluster of miRNAs in the midst of the cancer networkThe International Journal of Biochemistry & Cell Biology, 2010
- microRNAs and the immune responseCurrent Opinion in Pharmacology, 2009
- Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signalsProceedings of the National Academy of Sciences, 2009
- MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cellsProceedings of the National Academy of Sciences, 2009
- Modulation of the antitumor immune response by complementNature Immunology, 2008
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 proteinJournal of Experimental Medicine, 2008
- Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cellsCancer Immunology, Immunotherapy, 2008
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNature Medicine, 2007
- All-trans-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer PatientsCancer Research, 2006
- NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responsesProceedings of the National Academy of Sciences, 2006